Cheryl Cohen - Net Worth and Insider Trading

Cheryl Cohen Net Worth

The estimated net worth of Cheryl Cohen is at least $14 Million dollars as of 2024-11-12. Cheryl Cohen is the Director of NantKwest Inc and owns about 270,925 shares of NantKwest Inc (NK) stock worth over $9 Million. Cheryl Cohen is the Chief Commercial Officer of Medivation Inc and owns about 50,878 shares of Medivation Inc (MDVN) stock worth over $4 Million. Cheryl Cohen is also the Director of ImmunityBio Inc and owns about 200,617 shares of ImmunityBio Inc (IBRX) stock worth over $993,054. Besides these, Cheryl Cohen also holds Immunic Inc (IMUX) . Details can be seen in Cheryl Cohen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cheryl Cohen has not made any transactions after 2021-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Cheryl Cohen

Cheryl Cohen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cheryl Cohen owns 13 companies in total, including NantKwest Inc (NK) , MEI Pharma Inc (MEIP) , and Aerpio Pharmaceuticals Inc (ARPO) among others .

Click here to see the complete history of Cheryl Cohen’s form 4 insider trades.

Insider Ownership Summary of Cheryl Cohen

Ticker	Comapny	Transaction Date	Type of Owner
NK	NantKwest Inc	2020-08-11	director
MEIP	MEI Pharma Inc	2020-04-10	director
ARPO	Aerpio Pharmaceuticals Inc	2020-06-24	director
		2017-06-30	director
		2018-09-12	director
		2015-06-23	director
		2014-02-18	Chief Commercial Officer
		2021-08-23	director
		2018-06-20	director
		2021-01-27	director
		2021-01-27	director
		2023-06-15	director
		2021-01-27	director

Cheryl Cohen Latest Holdings Summary

Cheryl Cohen currently owns a total of 4 stocks. Among these stocks, Cheryl Cohen owns 270,925 shares of NantKwest Inc (NK) as of August 11, 2020, with a value of $9 Million and a weighting of 63.15%. Cheryl Cohen owns 50,878 shares of Medivation Inc (MDVN) as of October 24, 2013, with a value of $4 Million and a weighting of 29.73%. Cheryl Cohen also owns 200,617 shares of ImmunityBio Inc (IBRX) as of August 23, 2021, with a value of $993,054 and a weighting of 7.12%. The other 1 stocks Immunic Inc (IMUX) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Cheryl Cohen

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NK	NantKwest Inc	2020-08-11	270,925	32.49	8,802,353
MDVN	Medivation Inc	2013-10-24	50,878	81.44	4,143,504
IBRX	ImmunityBio Inc	2021-08-23	200,617	4.95	993,054
IMUX	Immunic Inc	2018-09-12	0	1.15	0

Holding Weightings of Cheryl Cohen

Cheryl Cohen Form 4 Trading Tracker

According to the SEC Form 4 filings, Cheryl Cohen has made a total of 1 transactions in NantKwest Inc (NK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NantKwest Inc is the sale of 30,000 shares on August 11, 2020, which brought Cheryl Cohen around $298,800.

According to the SEC Form 4 filings, Cheryl Cohen has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 100,000 shares on October 24, 2013, which brought Cheryl Cohen around $3 Million.

According to the SEC Form 4 filings, Cheryl Cohen has made a total of 2 transactions in ImmunityBio Inc (IBRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in ImmunityBio Inc is the sale of 24,777 shares on August 23, 2021, which brought Cheryl Cohen around $249,504.

More details on Cheryl Cohen's insider transactions can be found in the Insider Trading History of Cheryl Cohen table.

Insider Trading History of Cheryl Cohen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cheryl Cohen Trading Performance

GuruFocus tracks the stock performance after each of Cheryl Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cheryl Cohen is 21.55%. GuruFocus also compares Cheryl Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cheryl Cohen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cheryl Cohen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cheryl Cohen

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	36.05
Relative Return to S&P 500(%)	35.2

Cheryl Cohen Ownership Network

Ownership Network List of Cheryl Cohen

No Data

Ownership Network Relation of Cheryl Cohen

Cheryl Cohen Owned Company Details

What does NantKwest Inc do?

Who are the key executives at NantKwest Inc?

Cheryl Cohen is the director of NantKwest Inc. Other key executives at NantKwest Inc include director & See remarks Barry J. Simon , Chief Financial Officer Sonja Nelson , and director & 10 percent owner & Chairman and CEO Patrick Soon-shiong .

NantKwest Inc (NK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NantKwest Inc (NK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NantKwest Inc (NK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NantKwest Inc (NK)'s detailed insider trading history can be found in Insider Trading Tracker table.

NantKwest Inc Insider Transactions

No Available Data

What does MEI Pharma Inc do?

Who are the key executives at MEI Pharma Inc?

Cheryl Cohen is the director of MEI Pharma Inc. Other key executives at MEI Pharma Inc include Chief Medical Officer Richard G Ghalie , 10 percent owner Amin Nathoo , and 10 percent owner Funicular Funds, Lp .

MEI Pharma Inc (MEIP) Insider Trades Summary

Over the past 18 months, Cheryl Cohen made no insider transaction in MEI Pharma Inc (MEIP). Other recent insider transactions involving MEI Pharma Inc (MEIP) include a net purchase of 201,660 shares made by Anson Funds Management Lp , and a net purchase of 134,440 shares made by Funicular Funds, Lp .

In summary, during the past 3 months, insiders sold 0 shares of MEI Pharma Inc (MEIP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MEI Pharma Inc (MEIP) were sold and 336,100 shares were bought by its insiders, resulting in a net purchase of 336,100 shares.

MEI Pharma Inc (MEIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

MEI Pharma Inc Insider Transactions

No Available Data

What does Aerpio Pharmaceuticals Inc do?

Who are the key executives at Aerpio Pharmaceuticals Inc?

Cheryl Cohen is the director of Aerpio Pharmaceuticals Inc. Other key executives at Aerpio Pharmaceuticals Inc include director & 10 percent owner Orbimed Advisors Llc , Vice President of Finance Regina Marek , and director & President Joseph H. Gardner .

Aerpio Pharmaceuticals Inc (ARPO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerpio Pharmaceuticals Inc (ARPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerpio Pharmaceuticals Inc (ARPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerpio Pharmaceuticals Inc (ARPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerpio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Eledon Pharmaceuticals Inc do?

Who are the key executives at Eledon Pharmaceuticals Inc?

Cheryl Cohen is the director of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and director & Chief Executive Officer David-alexandre C Gros .

Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eledon Pharmaceuticals Inc Insider Transactions

No Available Data

What does Immunic Inc do?

Who are the key executives at Immunic Inc?

Cheryl Cohen is the director of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .

Immunic Inc (IMUX) Insider Trades Summary

Over the past 18 months, Cheryl Cohen made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 14,000 shares made by Daniel Vitt , and a net purchase of 5,000 shares made by Glenn Whaley .

In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 19,000 shares were bought by its insiders, resulting in a net purchase of 19,000 shares.

Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immunic Inc Insider Transactions

No Available Data

What does LadRx Corp do?

Who are the key executives at LadRx Corp?

Cheryl Cohen is the director of LadRx Corp. Other key executives at LadRx Corp include Chief Executive Officer Stephen Snowdy , Pres. & Chief Operating Officer Eric Curtis , and Vice President Drug Discovery Felix Kratz .

LadRx Corp (LADX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of LadRx Corp (LADX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LadRx Corp (LADX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

LadRx Corp (LADX)'s detailed insider trading history can be found in Insider Trading Tracker table.

LadRx Corp Insider Transactions

No Available Data

What does Medivation Inc do?

Who are the key executives at Medivation Inc?

Cheryl Cohen is the Chief Commercial Officer of Medivation Inc. Other key executives at Medivation Inc include Chief Operating Officer Marion Mccourt , VP & Finance and Accounting Tseli Lily Yang , and Interim Chief Medical Officer Mohammad Hirmand .

Medivation Inc (MDVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Medivation Inc (MDVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medivation Inc (MDVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Medivation Inc (MDVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Medivation Inc Insider Transactions

No Available Data

What does ImmunityBio Inc do?

Who are the key executives at ImmunityBio Inc?

Cheryl Cohen is the director of ImmunityBio Inc. Other key executives at ImmunityBio Inc include director & 10 percent owner & See remarks Patrick Soon-shiong , 10 percent owner California Capital Equity, Llc , and 10 percent owner Nant Capital, Llc .

ImmunityBio Inc (IBRX) Insider Trades Summary

Over the past 18 months, Cheryl Cohen made no insider transaction in ImmunityBio Inc (IBRX). Other recent insider transactions involving ImmunityBio Inc (IBRX) include a net purchase of 71,915 shares made by Michael D Blaszyk , a net purchase of 25,000 shares made by John Owen Brennan , and a net purchase of 7,000 shares made by Wesley Clark .

In summary, during the past 3 months, insiders sold 0 shares of ImmunityBio Inc (IBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmunityBio Inc (IBRX) were sold and 103,915 shares were bought by its insiders, resulting in a net purchase of 103,915 shares.

ImmunityBio Inc (IBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ImmunityBio Inc Insider Transactions

No Available Data

What does Aadi Bioscience Inc do?

Who are the key executives at Aadi Bioscience Inc?

Cheryl Cohen is the director of Aadi Bioscience Inc. Other key executives at Aadi Bioscience Inc include director & Chief Executive Officer David James Lennon , director & See Remarks Neil Desai , and Chief Financial Officer Scott M. Giacobello .

Aadi Bioscience Inc (AADI) Insider Trades Summary

Over the past 18 months, Cheryl Cohen made no insider transaction in Aadi Bioscience Inc (AADI). Other recent insider transactions involving Aadi Bioscience Inc (AADI) include a net sale of 660,000 shares made by Neil Desai , and a net sale of 9,689 shares made by David James Lennon .

In summary, during the past 3 months, insiders sold 49,689 shares of Aadi Bioscience Inc (AADI) in total and bought 0 shares, with a net sale of 49,689 shares. During the past 18 months, 669,689 shares of Aadi Bioscience Inc (AADI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 669,689 shares.

Aadi Bioscience Inc (AADI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aadi Bioscience Inc Insider Transactions

No Available Data

What does Ignyte Acquisition Corp do?

Who are the key executives at Ignyte Acquisition Corp?

Cheryl Cohen is the director of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .

Ignyte Acquisition Corp (IGNYU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNYU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ignyte Acquisition Corp Insider Transactions

No Available Data

What does Ignyte Acquisition Corp do?

Who are the key executives at Ignyte Acquisition Corp?

Cheryl Cohen is the director of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include 10 percent owner Ignyte Sponsor Llc , director & 10 percent owner & Co-Chief Executive Officer David I. Rosenberg , and director & 10 percent owner & Co-Chief Executive Officer David J. Strupp .

Ignyte Acquisition Corp (IGNY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ignyte Acquisition Corp Insider Transactions

No Available Data

What does Celldex Therapeutics Inc do?

Who are the key executives at Celldex Therapeutics Inc?

Cheryl Cohen is the director of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include director & President and CEO Anthony S Marucci , SVP & Chief Product Dev Officer Elizabeth Crowley , and SVP and CFO Samuel Bates Martin .

Celldex Therapeutics Inc (CLDX) Insider Trades Summary

Over the past 18 months, Cheryl Cohen made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .

In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 11,500 shares, with a net purchase of 11,500 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 11,500 shares were bought by its insiders, resulting in a net sale of 342,060 shares.

Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Celldex Therapeutics Inc Insider Transactions

No Available Data

What does Peak Bio Inc do?

Who are the key executives at Peak Bio Inc?

Cheryl Cohen is the director of Peak Bio Inc. Other key executives at Peak Bio Inc include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .

Peak Bio Inc (PKBO) Insider Trades Summary

Over the past 18 months, Cheryl Cohen made no insider transaction in Peak Bio Inc (PKBO). Other recent insider transactions involving Peak Bio Inc (PKBO) include a net purchase of 190,250 shares made by Hoyoung Huh ,

In summary, during the past 3 months, insiders sold 0 shares of Peak Bio Inc (PKBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Peak Bio Inc (PKBO) were sold and 190,250 shares were bought by its insiders, resulting in a net purchase of 190,250 shares.

Peak Bio Inc (PKBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Peak Bio Inc Insider Transactions

No Available Data

Cheryl Cohen Mailing Address

Above is the net worth, insider trading, and ownership report for Cheryl Cohen. You might contact Cheryl Cohen via mailing address: C/o Medivation, Inc., 201 Spear St., 3rd Floor, San Francisco Ca 94105.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.